Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114737) titled 'Clinical trial of inhibin A kit' on Dec. 17, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Sichuan Provincial People's Hospital
Condition:
Polycystic ovary syndrome, gonadal dysfunction, etc.
Intervention:
Gold Standard:Beckman Coulter, Inc. (USA) produced the Inhibin A assay kit (chemiluminescence method) Access INHIBIN A, used as a comparative reagent.
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-02-28
Target Sample Size: Target condition:334;Difficult condition:0
Countries of Recruitment:
China
To know more, visit http...